Assessment of <sup>18</sup>F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

2020246 citationsJournal Articlebronze Open Access

Authors

Matthias Brendel · LMU Klinikum

Henryk Barthel · Leipzig University

Thilo van Eimeren · University Hospital Cologne

Kenneth Marek · Invicro (United States)

Leonie Beyer · LMU Klinikum

Mengmeng Song · LMU Klinikum

Carla Palleis ·

Abstract

This multicenter evaluation indicates a value of 18F-PI-2620 to differentiate suspected patients with PSP, potentially facilitating more reliable diagnosis of PSP.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Advanced Neuroimaging Techniques and Applications Alzheimer's disease research and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Neurology

Volume 77, Issue 11, pp. 1408-1408

DOI: 10.1001/jamaneurol.2020.2526

Field-Weighted Citation Impact: 12.95